HIV/AIDS Treatment Guidelines Search Results| NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 41 – 60 of 67

Special Populations: Transplantation in People With HIV

Special Populations: Women With HIV

Considerations for Antiretroviral Use in People With Coinfections

Hepatitis B Virus/HIV Coinfection

Hepatitis C Virus/HIV Coinfection

Tuberculosis/HIV Coinfection

Limitations to Treatment Safety and Efficacy

Adherence to the Continuum of Care

Adverse Effects of Antiretroviral Medications

Cost Considerations and Antiretroviral Therapy

Drug-Drug Interactions

Overview: Drug-Drug Interactions between Antiretrovirals and Other Drugs

Drug-Drug Interactions: Protease Inhibitors and Other Drugs

Drug-Drug Interactions: Non-Nucleoside Reverse Transcriptase Inhibitors and Other Drugs

Drug-Drug Interactions: Nucleoside Reverse Transcriptase Inhibitors and Other Drugs

Drug-Drug Interactions: Integrase Strand Transfer Inhibitors and Other Drugs

Drug-Drug Interactions: CCR5 Antagonist and Other Drugs

Drug-Drug Interactions: HIV-1 gp120 Inhibitors and Other Drugs

Drug-Drug Interactions: Capsid Inhibitors and Other Drugs

Drug-Drug Interactions: Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors